ReviewFrontiers in medicine2026
Spatial multi-omics decoding of the fracture nonunion niche: from immune-vascular-skeletal crosstalk to precision regeneration.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fracture nonunion - the failure of bone to heal without surgical intervention - affects 5%-10% of all fractures and represents a substantial clinical and economic burden. Despite decades of research, the cellular and molecular mechanisms that distinguish successful repair from nonunion remain incompletely understood, largely because the fracture niche is a spatially organized, multicellular ecosystem whose crosstalk cannot be captured by bulk analyses. The recent convergence of spatial transcriptomics, single-cell multi-omics, spatial proteomics, and computational integration methods has opened a new era in which the fracture nonunion niche can be decoded at unprecedented resolution. Here we synthesize evidence from 2022 to 2025 that implicates three interdependent axes of niche dysfunction: (i) arrested macrophage polarization and chronic inflammation driven by dysregulated CSF1R, CD163, and T-cell signaling; (ii) uncoupled angiogenesis-osteogenesis despite preserved or elevated VEGF expression, mediated by impaired type H vessel formation and disrupted PDGF-BB/SLIT3/Notch signaling; and (iii) skewed skeletal stem and progenitor cell (SSPC) fate decisions toward fibrosis and adipogenesis at the expense of osteochondrogenic differentiation, governed by impaired BMP, Wnt, and IHH pathway activation. We then review how spatial multi-omics - including Visium, Xenium, MERFISH, imaging mass cytometry, and MALDI-mass spectrometry imaging - has mapped these axes
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.